EGFR antagonists in cancer treatment.
Ciardiello
Fortunato
F
Division of Medical Oncology, Department of Experimental and Clinical Medicine and Surgery F. Magrassi and A. Lanzara, Second University of Naples, Naples, Italy. fortunato.ciardiello@unina2.it
Tortora
Giampaolo
G
D000911:Antibodies, Monoclonal / Q000494:pharmacology / Q000627:therapeutic use; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy; D015179:Colorectal Neoplasms / Q000188:drug therapy; D004351:Drug Resistance; D066246:ErbB Receptors / Q000037:antagonists & inhibitors* / Q000235:genetics / Q000502:physiology; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy; D009154:Mutation; D009369:Neoplasms / Q000188:drug therapy*; D010190:Pancreatic Neoplasms / Q000188:drug therapy; D015398:Signal Transduction / Q000502:physiology
D000911:Antibodies, Monoclonal; D066246:ErbB Receptors